IASIS Healthcare reports solid revenue and EBITDA growth for fiscal first-quarter

IASIS Healthcare® LLC (“IASIS”) today announced financial and operating results for the fiscal first quarter ended December 31, 2009.

“We are pleased to announce another quarter of solid revenue and EBITDA growth. We believe these results further validate the strength of our integrated approach to operational excellence, strategic growth and financial stewardship.”

Net revenue for the first quarter totaled $629.0 million, an increase of 12.0%, compared to $561.6 million in the prior year quarter. Adjusted EBITDA for the first quarter totaled $71.7 million, an increase of 7.5%, compared to $66.7 million in the prior year quarter. A table describing adjusted EBITDA and reconciling net earnings from continuing operations to adjusted EBITDA is included in this press release in the attached Supplemental Consolidated Statements of Operations Information. Net earnings from continuing operations for the first quarter totaled $19.3 million, compared to $14.0 million in the prior year quarter.

Admissions and adjusted admissions increased 4.6% and 3.3%, respectively, in the first quarter, compared to the prior year quarter. Net patient revenue per adjusted admission increased 3.7% in the first quarter, compared to the prior year quarter.

In commenting on the first quarter results, David R. White, chairman and chief executive officer of IASIS Healthcare, said, “We are pleased to announce another quarter of solid revenue and EBITDA growth. We believe these results further validate the strength of our integrated approach to operational excellence, strategic growth and financial stewardship.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare